75 Participants Needed

Early Intervention Program for Autism Spectrum Disorder

MC
RL
AH
Overseen ByAntonio Hardan, MD
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Stanford University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a 12-week early intervention program designed to improve social communication skills in children with developmental disorders, such as Autism Spectrum Disorder. The Center Based Early Intervention Program provides an intensive learning environment, either in a center-based preschool setting or at home. It suits children aged 2 to just under 6 years who have been diagnosed with developmental disorders and can participate in standard testing. The trial explores whether this structured support can positively impact their daily interactions. As an unphased trial, it offers families a unique opportunity to contribute to groundbreaking research that could enhance early intervention strategies.

Do I need to stop my current medications to join the trial?

The trial protocol does not specify whether you need to stop taking your current medications.

What prior data suggests that this early intervention program is safe for children with developmental disorders?

Research shows that early intervention programs for autism spectrum disorder (ASD) are generally safe and well-received by young children. Studies have found that these programs can lead to positive results without major negative effects.

For instance, early intervention for autism has been associated with long-term improvements in communication and social skills. No strong evidence indicates serious side effects from these programs. Children who participated generally responded well.

The goal is to help children enhance their social communication skills, either in a center or at home. This personalized approach has proven both beneficial and safe for children with developmental disorders, like autism or intellectual disabilities.12345

Why are researchers excited about this trial?

Researchers are excited about the Early Intervention Program for Autism Spectrum Disorder because it offers flexible treatment options that adapt to different family needs. Unlike traditional therapies that may require frequent visits to a clinical setting, this program can be delivered either at a center or at home, making it more accessible and convenient for families. This flexibility could lead to more consistent therapy for children, potentially improving outcomes by integrating treatment into daily life. Additionally, early intervention is crucial for children with autism, and this program emphasizes starting treatment as soon as possible to maximize developmental gains.

What evidence suggests that this early intervention program is effective for social communication deficits in children with developmental disorders?

Research shows that early intervention programs can help young children with developmental disorders, such as Autism Spectrum Disorder (ASD), enhance their social communication skills. For example, studies have found that these programs can boost thinking abilities, language skills, and everyday behaviors in preschool-aged children. This trial will evaluate the effectiveness of a Center-Based or In-Home Early Intervention Program. Programs held in centers, where children learn in groups, have been linked to positive results. Research comparing home-based and center-based programs found that both can help children learn new skills. Some evidence even suggests that combining center-based programs with parent-focused activities can be a cost-effective way to achieve benefits. These findings support the idea that early intervention programs effectively help children with developmental disorders improve their social communication.35678

Who Is on the Research Team?

Antonio Hardan, M.D. | Stanford Medicine

Antonio Hardan, MD

Principal Investigator

Stanford University

Are You a Good Fit for This Trial?

This trial is for preschool-aged children (2 to almost 5 years old) diagnosed with developmental disorders like Autism Spectrum Disorder, neurogenetic disorders, or intellectual disability. They must be able to complete certain tests and have no severe psychiatric conditions like bipolar disorder.

Inclusion Criteria

I have been diagnosed with a developmental disorder like autism.
I am between 2 and 4 years old.
I have been diagnosed with a developmental disorder like autism.
See 3 more

Exclusion Criteria

Lack of availability during program hours
Current or lifetime diagnosis of severe psychiatric disorder (e.g., bipolar disorder, etc.)

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a 12-week early intervention program in an intensive center-based preschool environment or in the home

12 weeks
12 weekly sessions

Follow-up

Participants are monitored for changes in social communication deficits after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Center Based Early Intervention Program
  • Center Based or In Home Early Intervention Program
Trial Overview The study is testing a 12-week early intervention program aimed at improving social communication in young children with developmental disorders. It compares two settings: an intensive center-based preschool environment and in-home treatment.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Center Based or In-Home Early Intervention ProgramExperimental Treatment1 Intervention

Center Based Early Intervention Program is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Early Intervention Program for:
🇪🇺
Approved in European Union as Early Intervention Services for:
🇨🇦
Approved in Canada as Early Childhood Intervention for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+

John & Marcia Goldman Foundation

Collaborator

Trials
2
Recruited
120+

Published Research Related to This Trial

The Early Start Denver Model (ESDM) was effectively implemented in an Italian community setting, showing good feasibility through high retention rates and satisfaction among parents and therapists.
Children receiving ESDM for 2 hours per week over one year demonstrated greater improvements in communication, social skills, and maladaptive behaviors compared to a control group receiving standard treatment, indicating its efficacy in enhancing developmental outcomes for young children with autism.
Feasibility and Outcomes of the Early Start Denver Model Delivered within the Public Health System of the Friuli Venezia Giulia Italian Region.Devescovi, R., Colonna, V., Dissegna, A., et al.[2021]
Early Intensive Behavioral Intervention (EIBI) shows low-quality evidence of improving adaptive behavior and IQ in young children with autism spectrum disorders (ASD), based on a systematic review of five studies involving 219 children.
No adverse effects were reported, but the overall quality of evidence is low, indicating a need for more rigorous studies to better understand the effectiveness of EIBI in treating ASD.
Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD).Reichow, B., Hume, K., Barton, EE., et al.[2022]
The Frankfurt Early Intervention Program (FFIP) showed promising improvements in socialization skills and mental age in preschool-aged children with autism spectrum disorders after one year of therapy, with a treatment frequency of 2 hours per week.
While the results indicate medium effect sizes, they suggest that lower intensity interventions like FFIP may yield less cognitive gain compared to higher intensity programs, highlighting the need for further research through randomized-controlled studies.
The Frankfurt early intervention program FFIP for preschool aged children with autism spectrum disorder: a pilot study.Freitag, CM., Feineis-Matthews, S., Valerian, J., et al.[2021]

Citations

The Efficacy of Early Interventions for Children with Autism ...This study was aimed to investigate the efficacy of early interventions in improving the cognitive ability, language, and adaptive behavior of pre-school ...
Clinical outcomes of an early intervention program for ...This study evaluated the effectiveness of the ESDM for preschool-aged children with ASD using a predominantly group-based intervention in a community child ...
Autism intervention meta-analysis of early childhood ...Conclusion The available evidence on interventions to support young autistic children has approximately doubled in four years. Some evidence ...
Autism Spectrum Disorder following early intervention | NDTClinical outcomes of an early intervention program for preschool children with Autism spectrum disorder in a group setting. BMC Paediatr ...
Determining Associations Between Intervention Amount ...This meta-analysis investigates if the amount of intervention provided to young autistic children is associated with improved child ...
Early Intervention for Children With Autism Spectrum Disorder ...This article reviews current evidence for autism spectrum disorder (ASD) interventions for children aged <3 years, based on peer-reviewed articles published ...
7.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/23294523/
Clinical outcomes of an early intervention program for ...This study evaluated the effectiveness of the ESDM for preschool-aged children with ASD using a predominantly group-based intervention in a community child ...
LEAP–USA Follow-up Project | IESLEAP-USA was developed as a comprehensive intervention model for preschool children with autism. Based on inclusion with typically developing peers.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security